Venous thromboembolism prevention in acutely III nonsurgical patients

Keyphrases

• Acutely Ill Patients 100%
• Anticoagulants 40%
• Assessment Protocol 20%
• Dalteparin 20%
• Data Extraction 20%
• Disease States 20%
• Duration of Prophylaxis 40%
• Enoxaparin 20%
• Fondaparinux 20%
• Formulary 20%
• Hospitalization 20%
• Mechanical Method 20%
• Medical Inpatients 40%
• MEDLINE 20%
• Monotherapy 20%
• Non-surgical 40%
• Non-surgical Patients 100%
• Optimal Duration 40%
• Optimal Strategy 20%
• Optimal Timing 20%
• Patient Care 20%
• Population Definition 20%
• Prophylactic Treatment 20%
• Recent Advances 20%
• Renal Function 20%
• Risk Assessment 40%
• Risk Level 20%
• Risk Reduction 20%
• Risk Stratification 20%
• Specific Risk 20%
• State Duration 20%
• Unfractionated Heparin 20%
• Venous Thromboembolism 60%
• Venous Thromboembolism Prevention 100%

Medicine and Dentistry

• Antithrombotic 33%
• Awareness 16%
• Contraindication 33%
• Dalteparin Sodium 16%
• Disease 16%
• Fondaparinux 16%
• Heparin 16%
• Kidney Function 16%
• Monotherapy 16%
• Patient Care 16%
• Venous Thromboembolism 100%

Pharmacology, Toxicology and Pharmaceutical Science

• Anticoagulant Agent 33%
• Dalteparin 16%
• Disease 16%
• Enoxaparin 16%
• Fondaparinux 16%
• Heparin 16%
• Monotherapy 16%
• Venous Thromboembolism 100%